<DOC>
	<DOCNO>NCT02047552</DOCNO>
	<brief_summary>The purpose trial determine combination goal direct iron supplementation hepcidin mitigation safely eliminate serum bone marrow iron debt anemic , critically ill trauma patient functional iron deficiency .</brief_summary>
	<brief_title>A Randomized Controlled Pilot Study Goal-directed Iron Supplementation Anemic , Critically Ill Trauma Patients With Functional Iron Deficiency , With Without Oxandrolone</brief_title>
	<detailed_description>The inflammatory response associate traumatic critical illness rapidly induce functional iron deficiency , characterize hypoferremia , decrease transferrin saturation ( TSAT ) , hyperferritinemia , iron-deficient erythropoiesis ( IDE ) . These derangement iron metabolism primarily relate upregulation iron regulatory protein hepcidin , inhibit ferroportin-mediated release iron duodenal enterocytes macrophage . The resultant functional iron deficiency contribute intensive care unit ( ICU ) anemia increase pack red blood cell ( pRBCs ) transfusion requirement . Treatment strategies functional iron deficiency critically ill patient may divide broadly ( 1 ) iron supplementation ( 2 ) mitigation effect hepcidin . The goal treatment reverse serum iron debt , eliminate IDE , improve anemia , ultimately decrease pRBCs transfusion . Given approximately 90 % critically ill trauma patient ICU length stay ( LOS ) ≥ 7 day receive least one pRBCs transfusion , strategy even modest impact upon transfusion requirement likely improve overall health outcome substantially . Issues surround iron supplementation critically ill patient include formulation , dose , route administration , hepcidin antagonism , mitigation complication iron overload , particularly infection . Our first RCT iron supplementation critically ill surgical patient compare enteral ferrous sulfate 325 mg thrice daily placebo ( NCT00450177 ) . Although significant reduction pRBCs transfusion requirement iron group observe , low injury severity , intolerance enteral medication , predominance traumatic brain injury limited generalizability . In second multicenter RCT , compare intravenous iron sucrose 100 mg thrice weekly placebo among critically ill trauma patient ( NCT01180894 , NTI-ICU-008-01 ) [ 8 ] . Iron supplementation use generic dose scheme impact serum iron concentration , TSAT , IDE , anemia , pRBCs transfusion requirement . Rather , iron supplementation accumulate ferritin evidence significantly increase serum ferritin concentration iron compare placebo group time point . Iron supplementation increase risk infection either trial , despite relatively high incidence mark hyperferritinemia ( serum ferritin concentration &gt; 1,000 ng/mL ) iron group . The result trial suggest iron supplementation alone , use generic dose scheme , ineffective . The current pilot trial aim build upon finding prior two RCTs incorporate goal-directed iron supplementation hepcidin antagonism . The hypothesis combination goal direct iron supplementation hepcidin mitigation safely eliminate serum bone marrow iron debt anemic , critically ill trauma patient functional iron deficiency .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<mesh_term>Oxandrolone</mesh_term>
	<criteria>1 . Informed consent patient patient representative . 2 . Trauma patient 3 . Anemia ( hemoglobin &lt; 12 g/dL ) . 4 . Functional iron deficiency : 1 . Serum iron concentration &lt; 40 ug/dL 2 . TSAT &lt; 25 % 3 . Serum ferritin concentration &gt; 28 ng/mL 5 . &lt; 72 hour ICU admission . 6 . Expected ICU length stay ≥ 7 day . 1 . Age &lt; 18 year . 2 . Active bleed require pRBCs transfusion . 3 . Iron overload ( serum ferritin concentration ≥ 1,500 ng/mL ) . The serum ferritin concentration acute phase reactant increase critical illness regardless total body iron . Substantial level hyperferritinemia ( serum ferritin concentration &gt; 1,000 ng/dL ) observe NCT00450177 NCT01180894 without increase risk infection despite low TSAT IDE . For reason , believe relative hyperferritinemia ( serum ferritin concentration 500 1,500 ng/dL ) neither harmful indicative bone marrow iron availability . 4 . Infection , define use US Centers Disease Control Prevention ( CDC ) guideline , exception ventilatorassociated pneumonia ( VAP ) , define clinical suspicion pneumonia along low respiratory tract culture ≥ 105 colony form unit per mL . 5 . Chronic inflammatory condition ( e.g. , systemic lupus erythematosis , rheumatoid arthritis , ankylose spondylitis ) . 6 . Preexisting hematologic disorder ( e.g. , thalassemia , sickle cell disease , hemophilia , von Willibrand 's disease , myeloproliferative disease ) . 7 . Preexisting hepatic dysfunction ( cirrhosis , nonalcoholic steatohepatitis , hepatitis ) 8 . Current recent ( within 30 day ) use immunosuppressive agent . 9 . Use recombinant human erythropoietin formulation within previous 30 day . 10 . Known suspected carcinoma breast prostate . 11 . Nephrosis , nephrotic phase nephritis . 12 . Hypercalcemia ( serum calcium concentration &gt; 10.5 mg/dL ) . 13 . Pregnancy lactation . 14 . Legal arrest incarceration . 15 . Prohibition pRBCs transfusion . 16 . Stay ≥ 48 hour duration ICU transfer hospital . 17 . History intolerance hypersensitivity either iron oxandrolone . 18 . Moribund state death imminent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>trauma</keyword>
	<keyword>iron</keyword>
	<keyword>anemia</keyword>
	<keyword>red blood cell transfusion</keyword>
</DOC>